WELCOME
The Institute of Functional Genomics (IGF) is a multidisciplinary research centre which is developing a project focused on the functional genomics of physiological and pathological cellular communications in the fields of neurobiology, endocrinology, oncology and cardiology.
This project is based on a multi-scale strategy from 'molecule to systems' and combines structural, biochemical, genetic, epigenetic, omics, physiological and behavioural studies. A major effort is paid to the development of single-cell studies through multiple dimensions and multi-omic approaches, that are necessary to address the complexity of life.
The project of IGF is increasingly based on translational research, promoted by the recruitment of teams of clinicians from different fields (neurovascular, diabetology, neuro-oncology and psychiatry). The objective is to identify new mechanisms and concepts in the field of cellular communications, in order to develop new therapeutic strategies and diagnostic tools.
CANAUX IONIQUES ET PHYSIOPATHOLOGIES
9h00
Rémi Peyronnet, Head of Cell Biophysics, Université de Freiburg, Institut de Médecine Expérimentale Cardiovasculaire.
Piezo1 and BK channels in atrial fibrillation: remodelling and cross-talk in fibroblasts.
9h30
Patrick Bois, PU Université de Poitiers, STIM ERL 7368.
Le canal proton Hv1.
10h00
Flavien Charpentier, DR INSERM, Institut du thorax, Nantes.
Use of patient-specific iPS cell-derived cardiomyocytes to elucidate the cellular mechanisms of Brugada syndrome.
10h30 Pause-café
10h45
Jean-François Faivre, PU Université de Poitiers, STIM ERL 7368.
Remodelage phospholipidique membranaire et altération fonctionnelle dans le syndrome métabolique.
11h15
Marc Borsotto, DR CNRS, IPMC UMR.
First evidence of mini-spadin neuroprotective effects on stroke recovery and post-stroke depression.
11h45
Marie Demion, MCU Université de Montpellier, INSERM U1046.
Rôle des récepteurs aux prostanoïdes sur l’effet anti arythmique de la 4(RS)F4T-neuroprostane.
Powered by iCagenda